The U2-spliceosome and its interactors regulate the levels and activity of the LDL receptor in humans. (December 2020)

• Record Type: Journal Article
• Authors: Zanoni, P.; Panteloglou, G.; Othman, A.; Haas, J.T.; Meier, R.; Rimbert, A.; Futema, M.; Khalil, Y. Abou; Norrelykke, S.F.; Rzepiela, A.J.; Stoma, S.; Stebler, M.; Van Dijk, F.; Wijers, M.; Wolters, J.C.; Dalila, N.; Huijkman, N.; Smit, M.; Gallo, A.; Carreau, V.; Philippi, A.; Rabès, J.-P.; Boileau, C.; Visentin, M.; Vonghia, L.; Weyler, J.; Francque, S.M.; Verrijken, A.; Verhaegen, A.; Van Gaal, L.; Van Der Graaf, A.; Van Rosmalen, B.V.; Velagapudi, S.; Yalcinkaya, M.; Keel, M.; Radosavljevic, S.; Geier, A.; Tybjærg-Hansen, A.; Varret, M.; Rohrer, L.; Humphries, S.E.; Staels, B.; Van De Sluis, B.; Kuivenhoven, J.A.; Von Eckardstein, A.;
• Is Part Of: Atherosclerosis. Volume 315(2020)
• Page Start: e15
• Publication Date: 2020-12
• Subjects: Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2020.10.058
• Languages: English
• ISSNs: 0021-9150